Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The raptor-mTOR protein complex is a key component of a nutrient-sensitive signaling pathway that regulates cell size by controlling the accumulation of cellular mass. How nutrients regulate signaling through the raptor-mTOR complex is not well known. Here we show that a redox-sensitive mechanism regulates the phosphorylation of the raptor-mTOR effector S6K1, the interaction between raptor and mTOR, and the kinase activity of the raptor-mTOR complex. In cells treated with the oxidizing agents diamide or phenylarsine oxide, S6K1 phosphorylation increased and became insensitive to nutrient deprivation. Conversely, the reducing reagent BAL (British anti-Lewisite, also known as 2,3-dimercapto-1-propanol) inhibits S6K1 phosphorylation and stabilizes the interaction of mTOR and raptor to mimic the state of the complex under nutrient-deprived conditions. Our findings suggest that a redox-based signaling mechanism may participate in regulating the nutrient-sensitive raptor-mTOR complex and pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cysteine oxidation enhances phosphorylation of S6K, which is a direct readout of mTORC1 activation”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [117]
In the citing paper
“treatment with reducing agents effectively suppresses mTORC1 activation via inhibition of S6K phosphorylation”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [117]
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Self-citationSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Self-citationMammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Self-citationChung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,150
Cited by
Items 101–200 of 251
Guturi, K. K. N., Mandal, T., Chatterjee, A., Sarkar, M., Bhattacharya, S., Chatterjee, U., & Ghosh, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.324798 · Cited by 65
“Control shRNA (non-targeting to any known genomic loci) was constructed according to the standard protocol (25).”
MethodChapter 11 Monitoring Mammalian Target of Rapamycin (mTOR) Activity
Ikenoue, T., Hong, S., & Inoki, K. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03611-2 · Cited by 72
“Subconfluent cells are lysed in 1 ml of CHAPS lysis buffer (40 mM HEPES, pH 7.4, 120 mM NaCl, 2 mM EDTA, 0.3% CHAPS, 10 mM pyrophosphate, 10 mM glycerophosphate, 50 mM NaF, EDTA-free protease) containing protease and phosphatase inhibitors (Kim et al., 2002; Sarbassov and Sabatini 2005).”
MethodInfluentialRegulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism
Ryu, J. M., Lee, H. J., Jung, Y. H., Lee, K. H., Kim, D. I., Kim, J. Y., Ko, S. H., Choi, G. E., Chai, I. I., Song, E. J., et al. (2015) · International Journal of Stem Cells · doi:10.15283/ijsc.2015.8.1.24 · Cited by 65
“ROS can regulate the nutrient-sensing pathway through direct interaction with metabolic enzymes and proteins (32, 33), which could affect cellular processes such as cell cycle progression, apoptosis, quiescence, or differentiation”
BackgroundDDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress
Simonson, B., Subramanya, V., Chan, M. C., Zhang, A., Franchino, H. A., Ottaviano, F. G., Mishra, M. K., Knight, A. C., Hunt, D., Ghiran, I. C., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf5967 · Cited by 64
Redox control of chondrocyte differentiation and chondrogenesis
Bai, Y., Gong, X., Dou, C., Cao, Z., & Dong, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.443 · Cited by 64
Havel, J. J., Li, Z., Cheng, D., Peng, J., & Fu, H. (2015) · Oncogene · doi:10.1038/onc.2014.91 · Cited by 57
Ladelfa, M. F., Toledo, M. F., Laiseca, J. E., & Monte, M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3652 · Cited by 61
“Positive AKT signaling to mTOR stimulates cell proliferation by promoting biosynthesis of ribosomes, enhancing protein synthesis, and inhibiting autophagy (51, 128, 157).”
BackgroundRegulation of mTORC1 Complex Assembly and Signaling by GRp58/ERp57
Ramírez-Rangel, I., Bracho-Valdés, I., Vázquez-Macías, A., Carretero-Ortega, J., Reyes-Cruz, G., & Vázquez-Prado, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00824-10 · Cited by 60
“and mTORC2 complexes are regulated by phosphatidic acid (50) and by a complex formed by Tti1 and Tel2 (27), while nutrient availability and redox status have an effect on mTORC1 (47), opening the possibility that proteins that sense cellular redox status can be involved in the assembly of mTORC1 complex.”
BackgroundResultInfluentialRaptor-rictor axis in TGFβ-induced protein synthesis
Das, F., Ghosh‐Choudhury, N., Mahimainathan, L., Venkatesan, B. A., Féliers, D., Riley, D. J., Kasinath, B. S., & Choudhury, G. G. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.027 · Cited by 62
Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1
Zhang, L., Kimball, S. R., Jefferson, L. S., & Shenberger, J. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.001 · Cited by 52
Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia
Fähling, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01894.x · Cited by 57
“Furthermore, it has been demonstrated that mTOR activity and mTORC1 (the raptor containing complex) interaction is regulated in a redox-sensitive manner (Sarbassov & Sabatini 2005).”
BackgroundComplex N -Glycan and Metabolic Control in Tumor Cells
Mendelsohn, R., Cheung, P., Berger, L., Partridge, E., Lau, K., Datti, A., Pawling, J., & Dennis, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4580 · Cited by 57
“shown to activate mTOR in cultured human cells, whereas S6K1 phosphorylation becomes insensitive to nutrient deprivation (43).”
BackgroundHuang, Y., Kang, B. N., Tian, J., Liu, Y., Luo, H. R., Hester, L., & Snyder, S. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4489-06.2007 · Cited by 57
“In this context, Sarbassov and Sabatini (2005) recently showed that mTOR activity is regulated by a redox mechanism.”
Nishida, K., & Silver, P. A. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001269 · Cited by 60
“Although TORC1 activity has been suggested to be redoxsensitive [35,36], its redox control has not been demonstrated.”
BackgroundRule-Based Cell Systems Model of Aging using Feedback Loop Motifs Mediated by Stress Responses
Kriete, A., Bosl, W. J., & Booker, G. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000820 · Cited by 53
“However, it has also been found that higher levels of ROS can activate mTOR [72], which is physiologically relevant for responses to nutrition, but counteracting the beneficial suppression if chronically activated in aging.”
BackgroundOka, S., Hirata, T., Suzuki, W., Naito, D., Chen, Y., Chin, A., Yaginuma, H., Saito, T., Nagarajan, N., Zhai, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807735 · Cited by 57
“Although previous studies have shown that both PAO and diamide activate mTOR, the experiments were conducted with only one dosage at one time point (11, 12).”
BackgroundResultCheng, Y., Lin, S., Cao, Z., Yu, R., Fan, Y., & Chen, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114056 · Cited by 56
Hitting the Golden TORget: Curcumin’s Effects on mTOR Signaling
Beevers, C. S., Zhou, H., & Huang, S. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313070004 · Cited by 57
“It acts as a sensor of growth factor stimuli [25], nutrient [23, 49], energy [49], redox [50], and oxygen levels [51, 52] (Fig.”
BackgroundSuperoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex
Neklesa, T. K., & Davis, R. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807712105 · Cited by 52
Thelen, M. P., Wirth, B., & Kye, M. J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01101-6 · Cited by 54
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Open Biology · doi:10.1098/rsob.130185 · Cited by 60
“ROS and agents like PAO may either oxidize cysteine groups in the mTORC1 complex itself [96] or act at upstream levels, for example the TSC1/2 complex [97].”
BackgroundShawky, N. M., & Segar, L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.010 · Cited by 51
Impact of nutrient overload on metabolic homeostasis
Qiu, H., & Schlegel, V. L. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy023 · Cited by 56
Chen, S.-J., Nakahara, T., Takahara, M., Makiko, K. I. D. O., Dugu, L., Uchi, H., Takeuchi, S., Tu, Y.-T., Moroi, Y., & Furue, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08903.x · Cited by 50
Molecular Chaperones and Proteolytic Machineries Regulate Protein Homeostasis in Aging Cells
Margulis, B. A., Цимоха, А. С., Zubova, S. G., & Guzhova, I. V. (2020) · Cells · doi:10.3390/cells9051308 · Cited by 53
Rasinger, J. D., Lundebye, A., Penglase, S., Ellingsen, S., & Amlund, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040725 · Cited by 48
“RICTOR defines a distinct mammalian mTOR pathway which regulates protein kinase C alpha (PKCα) and protein kinase B (Akt/PKB) signalling networks [28].”
BackgroundIdentifying key regulators of the intestinal stem cell niche
Duckworth, C. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210223 · Cited by 52
Vukelic, M., Li, Y., & Kyttaris, V. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02658 · Cited by 49
“Mammalian Target of Rapamycin (mTOR) Signaling Inhibitor mTOR is a highly conserved serine/threonine kinase and is well known to be essential for the regulation of cell metabolism, growth, and proliferation (45, 46).”
BackgroundMitochondria in Early Forebrain Development: From Neurulation to Mid-Corticogenesis
Fame, R. M., & Lehtinen, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.780207 · Cited by 51
“Furthermore, ROS can also directly modify metabolic enzymes or proteins that participate in nutrient-sensing pathways to direct the metabolic flux (Brunelle et al., 2005; Sarbassov and Sabatini, 2005; Anastasiou et al., 2011).”
BackgroundConstitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders
El-Salem, M., Raghunath, P. N., Marzec, M., Wlodarski, P. K., Tsai, D. E., Hsi, E. D., & Wasik, M. A. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700494 · Cited by 47
“17 In turn, 4E-BP1 is a translational repressor that negatively regulates eukaryotic initiation factor 4Es4G (eIF-4EsG) complex by modulating phosphorylation of the involved proteins”
BackgroundZheng, C., Hou, Y., Liao, M.-T., Tsai, K., Hu, W., Yeh, C.-C., & Lu, K. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116802 · Cited by 54
Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer
Cormerais, Y., Vučetić, M., Parks, S. K., & Pouysségur, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010023 · Cited by 45
“Also, it has been shown that a pro-oxidative environment is able to inactivate the TSC complex, allowing GDP-GTP conversion of Rheb and consequent activation of mTORC1 even under nutrient starvation conditions [56,57].”
BackgroundDevaux, F., Lelandais, G., Garcia, M., Goussard, S., & Jacq, C. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.09.030 · Cited by 45
“In mammalian cells, hypoxia represses mTOR (mammalian TOR) as if the cells were exposed to rapamycin [30] and mTOR activity is regulated in a redox-sensitive manner [31], which establishes an homeostatic regulation loop between mTOR and mitochondria [32].”
Trewin, A. J., Lundell, L. S., Perry, B. D., Patil, K. V., Chibalin, A. V., Levinger, I., McQuade, L. R., & Stepto, N. K. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00605.2014 · Cited by 40
“Furthermore, given that the Akt/mTOR pathway can interact (40) and play a dual role in both insulin signaling and other protein synthesis regulation-signaling pathways (23), it is possible that ROS may also be involved in the regulation of the latter (41).”
BackgroundBasisty, N., Dai, D., Gagnidze, A., Gitari, L., Fredrickson, J., Maina, Y., Beyer, R. P., Emond, M. J., Hsieh, E. J., MacCoss, M. J., et al. (2016) · Aging Cell · doi:10.1111/acel.12472 · Cited by 44
“…signal synthesis and degradation of proteins as well as cellular fate, not unlike the nutrientsensitive mammalian target of rapamycin (mTOR) pathway (Sarbassov & Sabatini, 2005; Squier, 2006), and may therefore utilize some similar mechanisms to increase proteome half-lives and promote longevity.”
BackgroundWhaley‐Connell, A. T., Habibi, J., Nistala, R., DeMarco, V. G., Pulakat, L., Hayden, M. R., Joginpally, T., Ferrario, C. M., Parrish, A. R., & Sowers, J. R. (2011) · American Journal of Nephrology · doi:10.1159/000335079 · Cited by 40
Zhang, X., Rielland, M., Yalcin, S., & Ghaffari, S. (2011) · Current Drug Targets · doi:10.2174/138945011796150325 · Cited by 41
NOX4/H 2 O 2 /mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury
Kumar, V., Kurth, T. M., Zheleznova, N. N., Yang, C., & Cowley, A. W. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15058 · Cited by 40
Sun, D., Liu, H., Dai, X., Zheng, X., Yan, J., Wei, R., Fu, X., Huang, M., Shen, A., Huang, X., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.029 · Cited by 39
MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction
Kaadige, M. R., Yang, J., Wilde, B. R., & Ayer, D. E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00636-14 · Cited by 35
“ROS regulate MondoA and mTOR interaction.”
BackgroundResultInfluentialSvegliati, S., Amico, D., Spadoni, T., Fischetti, C., Finke, D., Moroncini, G., Paolini, C., Tonnini, C., Grieco, A., Rovinelli, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00075 · Cited by 43
“Cell proliferation and migration are thought to be a critical step in fibrogenesis, and since there is a strict interplay between mTOR and redox-based signaling (48, 49), we addressed the contribution of mTOR signaling to these phenotypes in cells exposed to ROS inducing stimuli.”
BackgroundNox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF
Tyurin‐Kuzmin, P. A., Zhdanovskaya, N., Sukhova, A. A., Sagaradze, G. D., Albert, E. A., Ageeva, L. V., Sharonov, G. V., Vorotnikov, A. V., & Va, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154157 · Cited by 36
“Because phosphorylation of Ser-473 is mediated by mechanistic target of rapamycin complex 2 (mTORC2) [46], the possibility arises that mTORC2 activity may be also redox-sensitive, similar to that reported for mTORC1 [47].”
BackgroundTumor suppressor NPRL2 induces ROS production and DNA damage response
Ma, Y., Silveri, L., LaCava, J., & Dokudovskaya, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-15497-0 · Cited by 37
The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness
Soh, R., Hardy, A., & Nieden, N. I. Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.022 · Cited by 34
“In HSCs, some level of AMPK is active, which can lead to FOXO activation to maintain the stem cell at low ROS levels and promote self-renewal [218,219].”
BackgroundRajesh, K., Krishnamoorthy, J., Gupta, J., Kazimierczak, U., Papadakis, A. I., Deng, Z., Wang, S., Kuninaka, S., & Koromilas, A. E. (2016) · Oncotarget · doi:10.18632/oncotarget.10480 · Cited by 34
“The ability of eIF2αP to promote LATS1 expression became further evident in experiments with the pro-oxidant drug phenylarsine oxide (PAO), which decreased LATS1 in the eIF2αP-deficient but not proficient HT1080 cells (Figure 2C) [18, 26].”
BackgroundZelenka, J., Dvořák, A., & Alán, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/351698 · Cited by 35
“Its activity is inhibited by the AMPK phosphorylation [43] but increased by shifting the cellular redox status towards the oxidation [44].”
BackgroundOxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome
Lai, Z., Marchena, I., & Perl, A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.024 · Cited by 32
“However, mTORC1 activity, which is responsive to oxidative stress (6;7), was similar within the immune system of SLE patients irrespective of APS status.”
BackgroundInfluentialTranslational responses to growth factors and stress
Cully, M., & Downward, J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370284 · Cited by 33
Huang, H. (2011) · Oncology Reports · doi:10.3892/or.2011.1573 · Cited by 29
“mTOR signals through several downstream effectors, including the 4E-BP1 (eukaryotic initiation factor 4E-binding protein) family of translational repressors and the S6Ks, to initiate ribosome translation of mRNA into protein (38).”
BackgroundVacuole-mediated selective regulation of TORC1-Sch9 signaling following oxidative stress
Takeda, E., Jin, N., Itakura, E., Kira, S., Kamada, Y., Weisman, L. S., Noda, T., & Matsuura, A. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-09-0553 · Cited by 31
Sin1-mediated mTOR signaling in cell growth, metabolism and immune response
Ruan, C., Ouyang, X., Liu, H., Li, S., Jin, J., Tang, W., Xia, Y., & Su, B. (2019) · National Science Review · doi:10.1093/nsr/nwz171 · Cited by 26
“Cellular redox status also regulates mTORC1 activity via cysteine oxidants in the absence of amino acids [39,43].”
BackgroundControl of DNA integrity in skeletal muscle under physiological and pathological conditions
Saada, Y. B., Zakharova, V., Chernyak, B. V., Dib, C., Carnac, G., Dokudovskaya, S., & Vassetzky, Y. S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2530-0 · Cited by 29
“ROS probably activate mTORC1 via oxidation of cysteine groups either in the mTORC1 complex itself [47] or in some of its upstream regulators [48].”
BackgroundGokey, J. J., Dasgupta, A., & Amack, J. D. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.08.002 · Cited by 30
“The mTOR pathway has been shown to affect cell metabolism and proliferation (Sarbassov and Sabatini, 2005), and decreased mTOR activity reduced cilia length in KV and caused LR patterning defects (Yuan et al.”
Cheng, S.-H., Tseng, Y.-M., Wu, S., Tsai, S., & Tsai, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-14159-5 · Cited by 26
The Exacerbation of Aging and Oxidative Stress in the Epididymis of Sod1 Null Mice
Noblanc, A., Klaassen, A., & Robaire, B. (2020) · Antioxidants · doi:10.3390/antiox9020151 · Cited by 28
Dames, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058404 · Cited by 26
Kim, Y. S., Kimball, S. R., Piskounova, E., Begley, T. J., & Hempel, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317846121 · Cited by 28
Whaley‐Connell, A. T., Habibi, J., Rehmer, N., Ardhanari, S., Hayden, M. R., Pulakat, L., Krueger, C., Ferrario, C. M., DeMarco, V. G., & Sowers, J. R. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.012 · Cited by 25
“[45] Ohnishi H, Kobayashi H, Okazawa H, et al.”
BackgroundToward an Integrated Understanding of Retrograde Control of Photosynthesis
Dietz, K., Wesemann, C., Wegener, M., & Seidel, T. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7519 · Cited by 27
“On treatment with oxidizing agents, S6K phosphorylation increases in an mTOR-dependent manner and displays in-sensitivity to nutrient deprivation (124).”
Cimmino, T. P., Pagano, E., Stornaiuolo, M., Esposito, G., Ammendola, R., & Cattaneo, F. (2022) · Antioxidants · doi:10.3390/antiox11091692 · Cited by 23
“Redox-sensitive mechanisms control the phosphorylation of S6K1, the interaction between S6K1 and mTORC1, and the kinase activity of the S6K1-mTORC1 complex [73].”
BackgroundThe Impact of Biosampling Procedures on Molecular Data Interpretation
Sköld, K., Alm, H., & Scholz, B. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.024869 · Cited by 25
da Rosa, H. T., Panzenhagen, A. C., Schmidtt, V., Teixeira, A. A., Espitia-Pérez, P., Franco, Á. D. O., Mingori, M. R., Torres, J. F., Schnorr, C. E., Hermann, P. R. S., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125400 · Cited by 24
mTOR Signaling in Lymphangioleiomyomatosis
Kristof, A. S. (2010) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0019 · Cited by 27
Glorieux, C., Enriquez-Lara, C., & Calderón, P. B. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116729 · Cited by 23
mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo
Zhang, Y., Xu, S., Lin, J., Yao, G., Han, Z., Liang, B., Zou, Z., Chen, Z., Song, Q., Dai, Y., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2270-7 · Cited by 24
“Interestingly, although previous study has shown that a reducing agent suppresses amino acid-induced mTORC1 activity [34], NDGA did not function as a reducing agent to stabilize the interaction of mTOR and Raptor to mimic the state of the complex under nutrientdeprived conditions.”
Hypothalamic stearoyl-CoA desaturase-2 (SCD2) controls whole-body energy expenditure
de Moura, R. F., do Nascimento, L. F. E., Ignácio-Souza, L. M., Morari, J., Razolli, D. S., Solon, C., de Souza, G. F. P., Festuccia, W. T., & Velloso, L. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.188 · Cited by 24
Mimoto, R., Nihira, N. T., Hirooka, S., Takeyama, H., & Yoshida, K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.015 · Cited by 22
“Akt is phosphorylated at Ser473 by PDK1 and at Thr308 by mTORC2 [18,19].”
BackgroundChen, S., Nakahara, T., Uchi, H., Takeuchi, S., Takahara, M., Makiko, K. I. D. O., Dugu, L., Tu, Y., Moroi, Y., & Furue, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09179.x · Cited by 22
NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function
Chen, J., Liu, C., Chernatynskaya, A., Newby, B. N., Brusko, T. M., Xu, Y., Barra, J. M., Morgan, N. N., Santarlas, C., Reeves, W. H., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200691 · Cited by 21
Lee, H., Fei, Q., Streicher, A., Zhang, W., Isabelle, C., Patel, P., Lam, H. C., Arciniegas, A. J. L., Pinilla-Vera, M., Amador-Munoz, D. P., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.137708 · Cited by 22
“Given that physical forces during MV are known to release reactive oxygen species (9, 71) and mTORC1 can be regulated in a redox sensitive fashion (72, 73), we examined the role of ROS in activating mTORC1 during VILI.”
mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss
Cortada, M., Levano, S., & Bodmer, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126368 · Cited by 22
Ando, T., Suzuki‐Karasaki, M., Suzuki‐Karasaki, M., Ichikawa, J., Ochiai, T., Yoshida, Y., Haro, H., & Suzuki‐Karasaki, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.593127 · Cited by 20
Conserved versatile master regulators in signalling pathways in response to stress in plants
Balderas‐Hernández, V. E., Alvarado-Rodríguez, M., & Fraire-Velázquez, S. (2013) · AoB Plants · doi:10.1093/aobpla/plt033 · Cited by 24
“DNA damage and redox stress also downregulate TOR signalling (Feng et al. 2005; Sarbassov and Sabatini 2005; Feng 2010).”
BackgroundUBTOR/KIAA1024 regulates neurite outgrowth and neoplasia through mTOR signaling
Zhang, H., Zhang, Q., Gao, G., Wang, X., Wang, T., Kong, Z., Wang, G., Zhang, C., Wang, Y., & Peng, G. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007583 · Cited by 18
Lebenzon, J. E., Torson, A. S., & Sinclair, B. J. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100906 · Cited by 22
Hari, A. S., Banerji, R., Liang, L., Fulton, R. E., Huynh, C. Q., Fabisiak, T., McElroy, P. B., Roede, J. R., & Patel, M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102895 · Cited by 18
Global and Gene-Specific Translational Regulation in Rat Lung Development
Otulakowski, G., Duan, W., & O'Brodovich, H. M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0284oc · Cited by 16
Evidence that a mitochondrial death spiral underlies antagonistic pleiotropy
Stern, M. (2017) · Aging Cell · doi:10.1111/acel.12579 · Cited by 19
Investigating mammalian target of rapamycin inhibitors for their anticancer properties
Smolewski, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.10.1201 · Cited by 16
“Recently, Sarbassov and Sabatini [13] suggested that nutrients regulate signalling through mTORC1 by the redox-based mechanism.”
BackgroundMetabolic regulation of quiescence in plants
Considine, M. J., & Foyer, C. H. (2023) · The Plant Journal · doi:10.1111/tpj.16216 · Cited by 17
“All of these enzymes are either directly regulated by redox post-PTMs or are indirectly modulated by changes in cellular redox state (Hene-berg, 2019; Sarbassov & Sabatini, 2005; Wurzinger et al., 2017).”
BackgroundLiu, T., Yang, K.-X., Yu, J., Cao, Y., Ren, J.-S., Hao, J., Pan, B.-Q., Ma, S., Yang, L.-Y., Cai, Y., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1663-4 · Cited by 15
Cassano, T., Giamogante, F., Calcagnini, S., Romano, A., Lavecchia, A. M., Inglese, F., Paglia, G., Bukke, V. N., Romano, A. D., Friuli, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033005 · Cited by 14
“In this regard, Sarvassov and Sabatini demonstrated that thiol oxidants decrease the interaction between Raptor and mTOR, whereas a reducing reagent stabilizes this complex [77].”
BackgroundAiken, K. J., Bickford, J. S., Kilberg, M. S., & Nick, H. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709944200 · Cited by 14
Mony, V. K., Drangowska-Way, A., Albert, R., Harrison, E., Ghaddar, A., Horak, M. K., Ke, W., & O’Rourke, E. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104832118 · Cited by 15
“In mammalian systems, mTORC1 is activated upon oxidative stress (47).”
BackgroundAbetov, D. A., Kiyan, V. S., Zhylkibayev, A. A., Sarbassova, D. A., Alybayev, S., Spooner, E., Song, M. S., Bersimbaev, R. I., & Sarbassov, D. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.008378 · Cited by 13
Self-citationHSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells
Stankova, K., Savova, G., Nikolov, V., & Boteva, R. (2014) · Dose-Response · doi:10.2203/dose-response.14-039.stankova · Cited by 12
“…with GA, may act as a mediator of adaptive ROS signal which activates pathways linking the cellular antioxidant response to unfolded protein response (Sarbassov and Sabatini 2005) as shown by the concerted up-regulation of key enzymes of the radical scavenging systems such as MnSOD and catalase.”
BackgroundTo Claim Growth Turf, mTOR Says SOD Off
Kong, H., & Chandel, N. S. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.015 · Cited by 11
“Interestingly, increasing the cytosolic oxidizing environment in mammalian cells has been shown to activate mTORC1 activity through unknown mechanisms (Sarbassov and Sabatini, 2005).”
BackgroundChronic Interstitial Nephritis in Agricultural Communities
Holliday, M. W., Majeti, R. N., & Sheikh‐Hamad, D. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000312 · Cited by 11
Tsubaki, M., Takeda, T., Asano, R., Matsuda, T., Fujimoto, S.-I., Itoh, T., Imano, M., Satou, T., & Nishida, S. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.10.019 · Cited by 10
“It has been indicated that the cytotoxic effect of anticancer drugs is related to ROS production, which activates the mTOR pathway (Sarbassov and Sabatini, 2005; Liu et al., 2016; Sun et al., 2015).”
BackgroundInflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia
Đikić, D., Bogdanovic, A. D., Marković, D. C., Ajtić, O. M., Subotički, T., Diklić, M., Vukotić, M., Dragojević, T., Živković, E., Santibanez, J. F., et al. (2022) · Biomolecules · doi:10.3390/biom12020247 · Cited by 13
“It is assumed that TOR in the cell is in a reduced and oxidized form, and their relationship is determined by factors that otherwise regulate the cell’s redox potential, including ROS [50,55].”
BackgroundHyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
Tong, W.-H., Ollivierre, H., Noguchi, A. C., Ghosh, M. C., Springer, D., & Rouault, T. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2022.e10371 · Cited by 10
Mas‐Parés, B., Xargay‐Torrent, S., Gómez‐Vilarrubla, A., Carreras‐Badosa, G., Prats‐Puig, A., de Zegher, F., Ibáñez, L., Bassols, J., & López‐Bermejo, A. (2023) · Nutrients · doi:10.3390/nu15143175 · Cited by 9
“RPTOR, the regulatory-associated protein of mTOR, is known to play a role in lipogenesis by controlling mTORC1 activity [44] and regulates cell growth in response to nutrient and insulin levels [45].”
BackgroundThe Target of Rapamycin: Structure and Functions
Wu, C., Chou, P., & Jacinto, E. (2012) · InTech eBooks · doi:10.5772/37927 · Cited by 9
Mitochondrial dysfunction as the “mother” of all hallmarks of aging
Weissig, V. (2025) · Journal of Mitochondria Plastids and Endosymbiosis · doi:10.1080/28347056.2025.2560191 · Cited by 11
Sommer, L. A. M., & Dames, S. A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.031 · Cited by 7
An emerging role for cysteine-mediated redox signaling in aging
Jin, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103852 · Cited by 9
“PAO and diamide also suppress mTOR interaction with the mTORC1 subunit raptor, raising the possibility that mTOR or raptor may be modified by these oxidants [225,226].”
Sikalidis, A. K. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.738649 · Cited by 8
Molecular Mechanisms in Arsenic Toxicity
Watson, W. H. (2015) · Advances in molecular toxicology · doi:10.1016/b978-0-12-802229-0.00003-7 · Cited by 6
Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application
Rubin, M., Artusi, I., & Cozza, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1632924 · Cited by 5
Kyttaris, V. C. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0638-8 · Cited by 5
Metadata
- Authors
- Sarbassov, D. D., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 47
- Pages
- 39505-39509
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2054943275
- Cited by
- 248
- References
- 32
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 16 · 2020: 14 · 2019: 6 · 2018: 12 · 2017: 21 · 2016: 13 · 2015: 15 · 2014: 12 · 2013: 16 · 2012: 12
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5448 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA103866, R01CA103866)
- National Institute of Allergy and Infectious Diseases (AI47389))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTOR signaling, redox regulation, S6K1 phosphorylation, nutrient sensing, cell size control, diamide, phenylarsine oxide, BAL, nutrient deprivation, oxidative stress
- MeSH terms
- Regulatory-Associated Protein of mTOR, Arsenicals, Cell Line, Diamide, Dimercaprol, Humans, Oxidation-Reduction, Phosphorylation, Protein Kinases, Proteins, Recombinant Proteins, Transfection, Signal Transduction, Oxidants, RNA, Small Interfering, Ribosomal Protein S6 Kinases, 70-kDa, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.